Stock Screener App

무료 -

설치하다

3.7108

2.35% -0.0892

Genenta Science Spa Adr (GNTA)

개요 뉴스 가격 이력 토론 예측

Genenta Science Spa Adr 주식(GNTA)의 최신 뉴스

Applying sector rotation models to Altice USA Inc.Free Risk Managed Intraday Trade Alerts - Newser

Genenta Science S.p.A. to Terminate Dedicated Suite Agreement with AGC Biologics - MSN

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX) and Gilead Sciences (GILD) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Esperion (ESPR) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: NextCure (NXTC), Lexaria Bioscience (LEXX) and Travere Therapeutics (TVTX) - The Globe and Mail

Genenta Science stock maintains Buy rating as Temferon shows promise in GBM - Investing.com

Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar - GlobeNewswire Inc.

Genenta secures $21.9 million for cancer drug trial By Investing.com - Investing.com South Africa

Genenta secures €20M in mandatory convertible bond deal - Investing.com India

Genenta secures €20M in mandatory convertible bond deal By Investing.com - Investing.com South Africa

Genenta secures $21.9 million for cancer drug trial - Investing.com India

Genenta Science Secures €20 Million Convertible Bond Financing for Oncology Research - TipRanks

Oncology Breakthroughs: How Cancer Research Is Advancing in 202527.02.25News - Ariva

Genenta Science announces amendment to pact with AGC Biologics - Yahoo Finance

Genenta Science Enhances Manufacturing Agreement with AGC Biologics - TipRanks

Genenta Science Announces Shareholder Meeting - TipRanks

symbol__ Stock Quote Price and Forecast - CNN

10 Best Italian Stocks To Buy Now - Yahoo Finance

INCY

$78.39

0.24%

RPRX

$37.58

1.54%

INSM

$109.55

0.23%

SMMT

$28.66

2.10%

BNTX

$111.66

0.28%

ONC

$288.18

3.39%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개